Research Papers:

Upregulation of miR-126-3p promotes human saphenous vein endothelial cell proliferation in vitro and prevents vein graft neointimal formation ex vivo and in vivo

Qingxi Qu, Weidong Bing, Xiangbin Meng, Jie Xi, Xiao Bai, Qing Liu, Yaqiu Guo, Xin Zhao and Yanwen Bi _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:106790-106806. https://doi.org/10.18632/oncotarget.22365

Metrics: PDF 1336 views  |   HTML 2437 views  |   ?  


Qingxi Qu1, Weidong Bing1, Xiangbin Meng1, Jie Xi1, Xiao Bai1, Qing Liu2, Yaqiu Guo3, Xin Zhao1 and Yanwen Bi1

1Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China

2Department of Ultrasound, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250012, China

3Department of Anesthesiology, Jinan Maternity and Child Health Care Hospital, Jinan, Shandong 250012, China

Correspondence to:

Yanwen Bi, email: [email protected]

Keywords: miRNAs, human saphenous vein, vein graft, endothelial cells, neointimal formation

Received: June 30, 2017     Accepted: August 27, 2017     Published: November 03, 2017


Poor long-term patency of vein grafts remains an obstacle in coronary artery bypass grafting (CABG) surgery using an autologous saphenous vein graft. Recent studies have revealed that miR-126-3p promotes vascular integrity and angiogenesis. We aimed to identify the role of miR-126-3p in the setting of vein graft disease and investigate the value of miR-126-3p agomir as a future gene therapy in vein graft failure. Expression analysis of circulating miR-126-3p in plasma from CABG patients established the basic clues that miR-126-3p participates in CABG. The in vitro results indicated that elevated miR-126-3p expression significantly improved proliferation and migration in human saphenous vein endothelial cells (HSVECs) by targeting sprouty-related protein-1 (SPRED-1) and phosphatidylinositol-3-kinase regulatory subunit 2 (PIK3R2), but not in human saphenous vein smooth muscle cells (HSVSMCs). Moreover, the therapeutic potential of miR-126-3p agomir was demonstrated in cultured human saphenous vein (HSV) ex vivo. Finally, local delivery of miR-126-3p agomir was confirmed to enhance reendothelialization and attenuate neointimal formation in a rat vein arterialization model. In conclusion, we provide evidence that upregulation of miR-126-3p by agomir possesses potential clinical value in the prevention and treatment of autologous vein graft restenosis in CABG.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 22365